Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Guest

Showing results (231-240 of 492) with videos related to

Pageof 50
Sort By:
Frontiers in Cell and Developmental Biology|June 25, 2021
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious DiseasesAisha Khan, Michael A Bellio, Ivonne H Schulman, et al.
BMJ Open|January 20, 2022
Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM)Alvaro Yanez Touzet, Aniqah Bhatti, Esmee Dohle, et al.
Experimental Neurology|June 4, 2013
Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?Brian K Kwon, Lesley J J Soril, Mark Bacon, et al.
Journal of Neurotrauma|June 6, 2023
Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded TrialMichael G Fehlings, Ali Moghaddamjou, James S Harrop, et al.
Spinal Cord|December 30, 2017
Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trialsLinda A T Jones, Anne Bryden, Tracey L Wheeler, et al.
JMIR Research Protocols|February 22, 2024
#4Corners4Health Social Media Cancer Prevention Campaign for Emerging Adults: Protocol for a Randomized Stepped-Wedge TrialDavid B Buller, Andrew L Sussman, Cynthia A Thomson, et al.
Global Spine Journal|February 17, 2022
A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and TimeBenjamin M Davies, Oliver Mowforth, Aref-Ali Gharooni, et al.
BMJ Open|June 9, 2022
Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)Benjamin M Davies, Alvaro Yanez Touzet, Oliver D Mowforth, et al.
BMC Medical Research Methodology|April 22, 2023
Lived experience-centred word clouds may improve research uncertainty gathering in priority setting partnershipsOliver D Mowforth, Lance Burn, Danyal Z Khan, et al.
Ebiomedicine|July 25, 2025
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.
Pageof 50

Showing results (231-240 of 492) with videos related to

Sort By:
Pageof 50
Frontiers in Cell and Developmental Biology|June 25, 2021
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious DiseasesAisha Khan, Michael A Bellio, Ivonne H Schulman, et al.
BMJ Open|January 20, 2022
Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM)Alvaro Yanez Touzet, Aniqah Bhatti, Esmee Dohle, et al.
Experimental Neurology|June 4, 2013
Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?Brian K Kwon, Lesley J J Soril, Mark Bacon, et al.
Journal of Neurotrauma|June 6, 2023
Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded TrialMichael G Fehlings, Ali Moghaddamjou, James S Harrop, et al.
Spinal Cord|December 30, 2017
Considerations and recommendations for selection and utilization of upper extremity clinical outcome assessments in human spinal cord injury trialsLinda A T Jones, Anne Bryden, Tracey L Wheeler, et al.
JMIR Research Protocols|February 22, 2024
#4Corners4Health Social Media Cancer Prevention Campaign for Emerging Adults: Protocol for a Randomized Stepped-Wedge TrialDavid B Buller, Andrew L Sussman, Cynthia A Thomson, et al.
Global Spine Journal|February 17, 2022
A New Framework for Investigating the Biological Basis of Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 5]: Mechanical Stress, Vulnerability and TimeBenjamin M Davies, Oliver Mowforth, Aref-Ali Gharooni, et al.
BMJ Open|June 9, 2022
Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)Benjamin M Davies, Alvaro Yanez Touzet, Oliver D Mowforth, et al.
BMC Medical Research Methodology|April 22, 2023
Lived experience-centred word clouds may improve research uncertainty gathering in priority setting partnershipsOliver D Mowforth, Lance Burn, Danyal Z Khan, et al.
Ebiomedicine|July 25, 2025
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueMichael G Fehlings, Karlo M Pedro, Mohammed Ali Alvi, et al.
Pageof 50